Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride I.P. 3mg + Metformin Hydrochloride (S.R.) I.P. 500mg Bi-Layered Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹129/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Gimtype M3 Tablet is a combination of Glimepiride 3mg and Metformin Hydrochloride 500mg in a sustained-release bi-layered formulation. It is designed to offer dual benefits in the management of type 2 diabetes mellitus by improving glycemic control. Glimepiride, a sulfonylurea, stimulates insulin secretion from the pancreas, while Metformin enhances insulin sensitivity and reduces hepatic glucose production. The bi-layered design ensures optimal release for prolonged efficacy.
May cause hypoglycemia, gastrointestinal discomfort, nausea, metallic taste, or weight gain. Metformin may rarely lead to lactic acidosis, a serious but uncommon complication.
Indicated for the management of type 2 diabetes mellitus in adults, especially in patients who require both insulin secretion stimulation and improved insulin sensitivity to control blood glucose levels.
Should be taken with meals to reduce the risk of gastrointestinal side effects. Regular blood sugar monitoring is essential. Not for use in type 1 diabetes or diabetic ketoacidosis. Use with caution in patients with renal or hepatic impairment.
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.
Composition : Rosuvastatin 10 mg tablet
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 10 mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + aspirin 75 mg tablet
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10 mg + Telmisartan 40 mg tablet
Composition : Atorvastatin Calcium I.P. 10mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination is widely used in type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, fasting and post-meal blood sugar control, insulin resistance, and long-term glycemic management. It is widely prescribed by physicians and diabetologists, and the bi-layered formulation helps improve compliance and therapeutic effectiveness.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 3mg + Metformin 500mg Bi-layered Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, lifelong therapy usage, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.